198 related articles for article (PubMed ID: 22271154)
1. Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease.
Krasemann S; Neumann M; Luepke JP; Grashorn J; Wurr S; Stocking C; Glatzel M
Acta Neuropathol; 2012 Jul; 124(1):111-26. PubMed ID: 22271154
[TBL] [Abstract][Full Text] [Related]
2. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
[TBL] [Abstract][Full Text] [Related]
3. Understanding the natural variability of prion diseases.
Geissen M; Krasemann S; Matschke J; Glatzel M
Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
[TBL] [Abstract][Full Text] [Related]
4. Detection of PrP in extraneural tissues.
Brown KL; Ritchie DL; McBride PA; Bruce ME
Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547
[TBL] [Abstract][Full Text] [Related]
5. Murine retroviral neurovirulence correlates with an enhanced ability ofvirus to infect selectively, replicate in, and activate resident microglial cells.
Baszler TV; Zachary JF
Am J Pathol; 1991 Mar; 138(3):655-71. PubMed ID: 2000941
[TBL] [Abstract][Full Text] [Related]
6. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity.
Krasemann S; Neumann M; Szalay B; Stocking C; Glatzel M
J Gen Virol; 2013 Feb; 94(Pt 2):453-463. PubMed ID: 23136363
[TBL] [Abstract][Full Text] [Related]
7. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
9. Quantitative variation of free amino acids in the central nervous system of MoMuLV-ts1-infected mice.
Stoica G; Barker R; Wu G; Lynn WS; Wong PK
In Vivo; 1998; 12(4):395-401. PubMed ID: 9706491
[TBL] [Abstract][Full Text] [Related]
10. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.
Brazier MW; Lewis V; Ciccotosto GD; Klug GM; Lawson VA; Cappai R; Ironside JW; Masters CL; Hill AF; White AR; Collins S
Brain Res Bull; 2006 Jan; 68(5):346-54. PubMed ID: 16377442
[TBL] [Abstract][Full Text] [Related]
11. Synaptic and dendritic pathology in murine retroviral encephalitis.
Nagra RM; Masliah E; Wiley CA
Exp Neurol; 1993 Dec; 124(2):283-8. PubMed ID: 8287927
[TBL] [Abstract][Full Text] [Related]
12. Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.
Friedman-Levi Y; Hoftberger R; Budka H; Mayer-Sonnenfeld T; Abramsky O; Ovadia H; Gabizon R
J Neuroinflammation; 2012 Mar; 9():58. PubMed ID: 22436404
[TBL] [Abstract][Full Text] [Related]
13. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
14. Murine retroviral-induced spongiform neuronal degeneration parallels resident microglial cell infection: ultrastructural findings.
Baszler TV; Zachary JF
Lab Invest; 1990 Nov; 63(5):612-23. PubMed ID: 2172651
[TBL] [Abstract][Full Text] [Related]
15. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of prion diseases.
Unterberger U; Voigtländer T; Budka H
Acta Neuropathol; 2005 Jan; 109(1):32-48. PubMed ID: 15645262
[TBL] [Abstract][Full Text] [Related]
17. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
18. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
[TBL] [Abstract][Full Text] [Related]
19. Antiprion properties of prion protein-derived cell-penetrating peptides.
Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
[TBL] [Abstract][Full Text] [Related]
20. Cells and prions: a license to replicate.
Nuvolone M; Aguzzi A; Heikenwalder M
FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
